✦ LIBER ✦

Expression of Receptor Activator of Nuclear Factor k-B Ligand (RANKL) in Neoplasms of Dogs and Cats

✍ Scribed by Anne M. Barger; Timothy M. Fan; Louis-Philippe de Lorimier; Ian T. Sprandel; Kristen O'Dell-Anderson

Book ID: 118094645
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 708 KB
Volume: 21
Category: Article
ISSN: 0891-6640
DOI: 10.1111/j.1939-1676.2007.tb02939.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Receptor Activator of Nuclear Factor-κB

Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis

✍ Atsushi Sasaki; Kenji Ishikawa; Naotsugu Haraguchi; Hiroshi Inoue; Tetsuya Ishio 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 358 KB

ROLE OF OSTEOPROGERIN AND RECEPTOR ACTIV

ROLE OF OSTEOPROGERIN AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KB LIGAND (RANKL) IN VASCULAR CALCIFICATION

✍ Hiromichi Taniwaki; Shuichi Jono; Atsushi Shioi; Akane Kizu; Yoshiki Nishizawa 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 55 KB

43 Assessment of receptor activator of n

43 Assessment of receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in lymphoma patients

✍ M. Ayoub; H. Gadallah; H. Hegab; D. Khattab; N. Mostafa 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Receptor Activator of Nuclear Factor κB

Receptor Activator of Nuclear Factor κB Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis

✍ Grimaud, Eva (author);Soubigou, Luc (author);Couillaud, Séverine (author);Coipea 📂 Article 📅 2003 🏛 American Society for Investigative Pathology Inc. 🌐 English ⚖ 692 KB

Receptor Activator of Nuclear Factor κB

Receptor Activator of Nuclear Factor κB Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis

✍ Grimaud, Eva (author);Soubigou, Luc (author);Couillaud, Séverine (author);Coipea 📂 Article 📅 2003 🏛 American Society for Investigative Pathology Inc. 🌐 English ⚖ 692 KB

Receptor Activator of Nuclear Factor Kap

Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Modulates the Expression of Genes Involved in Apoptosis and Cell Cycle in Human Osteoclasts

✍ Erika Rimondi; Marina Zweyer; Enrico Ricci; Roberto Fadda; Paola Secchiero 📂 Article 📅 2007 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 307 KB 👁 2 views

## Abstract It has been clearly established that receptor activator of nuclear factor kappa B ligand (RANKL) is a key cytokine involved in the differentiation of osteoclastic precursors of the monocytic/macrophagic lineage. However, relatively little information is available on the ability of RANKL